# Amisulpride

## Ribelite 200mg

| TAH Drug Code      | [ORIB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ORIB)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of psychoses, particularly acute or chronic schizophrenic disorders, characterized by postive symptoms (e.g. delirium, hallucinations, thought disorders) &/or negative symptoms (eg blunted emotions, emotional & social withdrawal), including when the negative symptoms predominate.                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | <=400 mg daily dose, single intake. >400 mg, in 2 divided doses. Predominant negative episode 50-300 mg/day as individualized dosage. Optimum dosage: 100 mg/day. Mixed episodes with positive & negative symptoms 400-800 mg/day as individualized dosage to maintain min effective dose. Acute psychotic episodes: Initiate with maximum 400 mg/day IM, replaced thereafter with 400-800 mg orally, maximum dosage: 1200 mg. Renal insufficiency CrCl 30-60 mL/min: reduce dose to 1/2. CrCl 10-30 mL/min: reduce dose to 1/3.                                                                                                   |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | Allergic to the active ingredient or other ingredients of the drug. Pheochromocytoma, known or suspected prolactin-related tumors, such as pituitary prolactin-secreting adenomas or breast cancer, or severe renal insufficiency (creatinine clearance <10 ml/min). Children under 15 years of age. Concomitant use with Class Ia antiarrhythmic drugs, such as quinidine, disopyramide; Class III antiarrhythmic drugs, such as amiodarone, sotalol; Other drugs, such as bepridil, cisapride, sultopride, thioridazine, methadone, IV erythromycin, IV vincamine, halofantrine, pentamidine, sparfloxacin, levodopa. Lactation. |
| Adverse Effects    | Common: Hypotension, Injection site pain (6%), Hypokalemia (4%), Prolactin level above reference range (5%), Abdominal distension symptom (2%), Shivering (4%) Serious: Prolonged QT interval                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| More Info          | [UpToDate](https://www.uptodate.com/contents/amisulpride-antipsychotic-oral-international-drug-information-concise)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

